ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,241Medicare Part D Prescriptions Filled, Including Refills

Rank: 216 out of 5176

$817K Total Retail Price of All Prescriptions

Rank: 426 out of 5176

476 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 13,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 612 551 1 4
DONEPEZIL HCL 583 564 2 28
FUROSEMIDE 555 552 3 8
CITALOPRAM HBR 514 496 4 31
METOPROLOL TARTRATE 489 456 5 6
SIMVASTATIN 419 375 6 1
LISINOPRIL 397 365 7 5
AMLODIPINE BESYLATE 372 372 8 2
WARFARIN SODIUM 357 329 9 13
RISPERIDONE 352 319 10 78
OMEPRAZOLE 338 284 11 3
QUETIAPINE FUMARATE 335 320 12 75
ALBUTEROL SULFATE 331 324 13 99
SERTRALINE HCL 284 264 14 30
DIVALPROEX SODIUM 245 231 15 104
PANTOPRAZOLE SODIUM 245 241 15 61
NAMENDA 244 235 17 47
IPRATROPIUM BROMIDE 241 236 18 135
KLOR-CON M20 226 224 19 129
MIRTAZAPINE 225 198 20 45
LEVEMIR 205 141 21 252
GABAPENTIN 192 169 22 21
NOVOLIN R 191 168 23 191
TAMIFLU 189 179 24 231
POTASSIUM CHLORIDE 186 185 25 34
CARBIDOPA-LEVODOPA 176 121 26 98
TRAMADOL HCL 134 106 27 40
ATENOLOL 133 114 28 12
METOPROLOL SUCCINATE 132 130 29 11
PREDNISONE 131 125 30 52
LANTUS 123 107 31 66
HUMULIN R 113 62 32 347
CYMBALTA 113 84 32 90
LEVETIRACETAM 112 85 34 92
CIPROFLOXACIN HCL 112 104 34 84
IPRATROPIUM-ALBUTEROL 101 91 36 138
TAMSULOSIN HCL 100 95 37 20
KLOR-CON M10 98 98 38 248
SEROQUEL 92 89 39 166
CLOPIDOGREL 91 91 40 26
BACLOFEN 85 56 41 173
DIGOXIN 83 83 42 56
METFORMIN HCL 80 61 43 7
CEPHALEXIN 78 74 44 189
PLAVIX 78 78 44 29
DIOVAN 77 64 46 19
ALENDRONATE SODIUM 72 69 47 18
ISOSORBIDE MONONITRATE ER 70 65 48 44
AZITHROMYCIN 70 70 48 42
DOXYCYCLINE HYCLATE 69 55 50 247
PRAVASTATIN SODIUM 68 51 51 23
GLIPIZIDE 68 66 51 63
NEXIUM 59 51 53 16
CARVEDILOL 57 57 54 24
TORSEMIDE 55 43 55 184
GENERLAC 55 30 55 506
CLONIDINE HCL 55 55 55 79
FINASTERIDE 54 54 58 69
TOPIRAMATE 53 36 59 314
RANITIDINE HCL 53 53 59 36
TRAZODONE HCL 53 41 59 71
SPIRIVA 53 52 59 54
LEVOFLOXACIN 52 47 63 109
TRAVATAN Z 51 50 64 234
DIVALPROEX SODIUM ER 51 51 64 270
LATANOPROST 50 46 66 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.